NCT02685969 Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants Status RECRUITING Phase N/A
NCT02672306 Safety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT02670993 Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease Status COMPLETED Phase NA
NCT02670083 A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). Status TERMINATED Phase PHASE3
NCT02656498 [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease Status COMPLETED Phase PHASE2
NCT02654574 Comparison of Two Modes of Administration of the IADL Questionnaire, Assessing the Level of Functional Autonomy of Patients to Carry Out the Tasks of Daily Living: Randomized Controlled Trial Among Patients of a Memory Clinic Status COMPLETED Phase NA
NCT02649985 PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases Status RECRUITING Phase PHASE1/PHASE2
NCT02648672 BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects Status COMPLETED Phase PHASE1
NCT02640092 Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Status COMPLETED Phase PHASE1
NCT02626572 Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms Status COMPLETED Phase PHASE2
NCT02621606 [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001) Status COMPLETED Phase PHASE1
NCT02615002 Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) Status COMPLETED Phase PHASE2
NCT02614131 A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD) Status TERMINATED Phase PHASE1
NCT02600130 Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT02586909 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension Status TERMINATED Phase PHASE3
NCT02585934 Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study Status COMPLETED Phase PHASE3
NCT02580305 SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Status COMPLETED Phase PHASE2